Endocrine Pathology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.6 | Q1 | 90.0% | 3.715 | Q1 | 98.4% |
| 2024 | 14.7 | Q1 | 98.9% | 3.832 | Q1 | 98.5% |
| 2023 | 11.3 | Q1 | 98.7% | 2.566 | Q1 | 97.1% |
| 2022 | 4.4 | Q1 | 77.9% | 0.944 | Q1 | 85.0% |
| 2021 | 4.1 | Q2 | 67.1% | 0.904 | Q1 | 84.3% |
| 2020 | — | — | 0.990 | Q1 | 85.2% | |
| 2019 | — | — | 0.886 | Q1 | 82.9% | |
| 2018 | — | — | 0.843 | Q1 | 80.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1046-3976
ISSN
1559-0097
country
UScoverage
1990-2026